BG91463A - Холестираминова таблетка и метод за получаването й - Google Patents

Холестираминова таблетка и метод за получаването й

Info

Publication number
BG91463A
BG91463A BG091463A BG9146390A BG91463A BG 91463 A BG91463 A BG 91463A BG 091463 A BG091463 A BG 091463A BG 9146390 A BG9146390 A BG 9146390A BG 91463 A BG91463 A BG 91463A
Authority
BG
Bulgaria
Prior art keywords
core
weight
agglomerates
tablet
cholestyramine
Prior art date
Application number
BG091463A
Other languages
English (en)
Other versions
BG60501B1 (bg
Inventor
Robert Bequette
Bruce Bonenberger
Claude Gallian
John Reckelhoff
Original Assignee
Bristol - Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol - Myers Squibb Company filed Critical Bristol - Myers Squibb Company
Publication of BG91463A publication Critical patent/BG91463A/bg
Publication of BG60501B1 publication Critical patent/BG60501B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Изобретението намира приложение във фармацевтичната промишленост. Таблетката се състои от сърцевина от холестираминови агломерати с обемно тегло в уплътнено състояние 0,45-0,5 г/мл и влагосъдържание от 8 до 14% тегловни. Агломератите са образувани от много малки, неправилно оформени с остри начупени краища с относително малко на брой големи гладки или плоски повърхности, като сърцевината има твърдост от 18 до 26 sсu, свободно от разтворител покритие, което включва в тегл.% От 60 до 95 стеаринова киселина, от 5 до 40 полиетиленгликол и от 10 до 20 частично хидрирано соево масло. По метода омокрените холестираминови частици се смилат в мелница за микронизиране и смлените частици се сушат при температура от 48 до 580с до влагосъдържание от 8 до 14% тегловни. Изсушеният материал се фракционира, при което се получават холестираминови агломерати, които се пресуват директно за получаване на сърцевина на таблетката. Върху сърцевината се нанася покритието, свободно от разтворител. 5 претенции
BG91463A 1989-03-16 1990-03-14 Холестираминова таблетка и метод за получаванетой BG60501B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (2)

Publication Number Publication Date
BG91463A true BG91463A (bg) 1993-12-24
BG60501B1 BG60501B1 (bg) 1995-06-30

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
BG91463A BG60501B1 (bg) 1989-03-16 1990-03-14 Холестираминова таблетка и метод за получаванетой

Country Status (34)

Country Link
US (1) US4956182A (bg)
EP (1) EP0387885B1 (bg)
JP (1) JP2974719B2 (bg)
KR (1) KR0140211B1 (bg)
CN (1) CN1047935C (bg)
AR (1) AR246012A1 (bg)
AT (1) ATE128031T1 (bg)
AU (1) AU617601B2 (bg)
BG (1) BG60501B1 (bg)
CA (1) CA2012300A1 (bg)
CS (1) CS277488B6 (bg)
CY (1) CY1899A (bg)
DD (1) DD292837A5 (bg)
DE (1) DE69022452T2 (bg)
DK (1) DK0387885T3 (bg)
EG (1) EG19669A (bg)
ES (1) ES2078917T3 (bg)
FI (1) FI92464C (bg)
GR (1) GR3017460T3 (bg)
HK (1) HK51396A (bg)
HU (1) HU209958B (bg)
IE (1) IE70591B1 (bg)
IL (1) IL93720A0 (bg)
MY (1) MY109744A (bg)
NO (1) NO176043C (bg)
NZ (1) NZ232864A (bg)
OA (1) OA09198A (bg)
PL (1) PL163301B1 (bg)
PT (1) PT93452B (bg)
RO (1) RO106953B1 (bg)
RU (1) RU2069558C1 (bg)
YU (1) YU52390A (bg)
ZA (1) ZA902001B (bg)
ZW (1) ZW1890A1 (bg)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
DK0782449T3 (da) * 1994-09-22 2003-08-04 Akzo Nobel Nv Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
CA2348871C (en) * 1998-11-02 2009-04-14 John G. Devane Multiparticulate modified release composition
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2283829A1 (en) 2000-10-30 2011-02-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
CN1491104A (zh) * 2001-02-13 2004-04-21 新型改进释放制剂
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
CA2447984A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Dosage forms having an inner core and outer shell with different shapes
RU2234915C2 (ru) * 2002-06-04 2004-08-27 Дж. Б. Кемикалс энд Фармасьютикалс Лтд. Твердая фармацевтическая композиция для перорального введения и способ ее получения
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
ES2400186T3 (es) * 2004-05-24 2013-04-08 Mepha Schweiz Ag Procedimiento para recubrimiento en seco
EA012220B1 (ru) * 2004-10-19 2009-08-28 Крка, Товарна Здравил, Д. Д., Ново Место Твёрдая фармацевтическая композиция, содержащая донепезила гидрохлорид
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
CA2622693C (en) 2005-09-15 2015-05-05 Genzyme Corporation Sachet formulation for amine polymers
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
WO2008018556A1 (fr) 2006-08-09 2008-02-14 Mitsubishi Tanabe Pharma Corporation Comprimé
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
US9993422B2 (en) 2012-04-18 2018-06-12 SpecGx LLC Immediate release, abuse deterrent pharmaceutical compositions
JP5469286B1 (ja) 2013-10-25 2014-04-16 株式会社クラレ 複層フィルム及びそれからなる合わせガラス用中間膜
HUE065006T2 (hu) * 2014-07-03 2024-04-28 SpecGx LLC Nem-cellulóz poliszacharidokat tartalmazó, visszaélés-gátló, azonnali felszabadulású készítmények
EP3413877B1 (en) * 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof
EP3413875B1 (en) * 2016-02-09 2020-01-29 Albireo AB Cholestyramine pellets and methods for preparation thereof
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
KR0140211B1 (ko) 1998-06-01
NO901183D0 (no) 1990-03-14
EG19669A (en) 1995-08-30
FI901241A0 (fi) 1990-03-13
KR900013946A (ko) 1990-10-22
CS277488B6 (en) 1993-03-17
DD292837A5 (de) 1991-08-14
HU901429D0 (en) 1990-06-28
RU2069558C1 (ru) 1996-11-27
PL163301B1 (en) 1994-03-31
RO106953B1 (ro) 1993-08-30
ES2078917T3 (es) 1996-01-01
IL93720A0 (en) 1990-12-23
JPH03236326A (ja) 1991-10-22
HUT54489A (en) 1991-03-28
ZW1890A1 (en) 1990-10-31
DE69022452T2 (de) 1996-03-14
EP0387885A2 (en) 1990-09-19
OA09198A (fr) 1992-06-30
US4956182A (en) 1990-09-11
BG60501B1 (bg) 1995-06-30
YU52390A (en) 1991-10-31
IE70591B1 (en) 1996-12-11
CA2012300A1 (en) 1990-09-16
HK51396A (en) 1996-03-29
AU5136790A (en) 1990-09-20
EP0387885B1 (en) 1995-09-20
CN1047935C (zh) 2000-01-05
DK0387885T3 (da) 1995-11-06
HU209958B (en) 1994-12-28
IE900941L (en) 1990-09-16
FI92464C (fi) 1994-11-25
ZA902001B (en) 1990-11-28
PT93452B (pt) 1996-12-31
CY1899A (en) 1990-03-15
JP2974719B2 (ja) 1999-11-10
NZ232864A (en) 1992-04-28
NO176043C (no) 1995-01-25
NO901183L (no) 1990-09-17
NO176043B (no) 1994-10-17
MY109744A (en) 1997-05-31
AR246012A1 (es) 1994-03-30
ATE128031T1 (de) 1995-10-15
PT93452A (pt) 1990-11-07
DE69022452D1 (de) 1995-10-26
CN1045921A (zh) 1990-10-10
FI92464B (fi) 1994-08-15
AU617601B2 (en) 1991-11-28
EP0387885A3 (en) 1992-06-17
GR3017460T3 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
KR830002513A (ko) 판크레아틴 제제 제조방법
FR2675398B1 (fr) Micro-capsules de filtres solaires, leur procede de preparation, les compositions cosmetiques et pharmaceutiques les comprenant et leurs applications.
NO176504C (no) Fremgangsmåte for fremstilling av en kosmetisk blanding
BE884992A (fr) Procede de preparation de suspensions ou de poudres stables de microcapsules stables et d'une porosite variable et produits ainsi obtenue
ES2053746T3 (es) Composicion para el tratamiento de la piel.
NL930095I2 (nl) Aromatische heterocyclische esters van steroiden, de bereiding daarvan en farmaceutische composities, die deze verbindingen bevatten.
EP0387885A3 (en) Direct compression cholestyramine tablet and solvent-free coating therefor
NO174062C (no) Fremgangsmåte for fremstilling av blekende granulat, samt anvendelse av granulatet
IT1196990B (it) Utilizzazione di polvere di grani di lupino dolce nella realizzazione di composizioni cosmetiche o dermofarmaceutiche, e composizioni ottenute
JPH0977636A (ja) 美白化粧品
Alder et al. Electrophoretic analysis of liver and testis histones of the frog Rana pipiens.
Perrie et al. A phosphorylated light-chain component of myosin
MX155639A (es) Composicion para matar el lustre de barnices a base de cera y procedimiento para su preparacion
ES8507152A1 (es) Un procedimiento para producir aditivos a piensos para animales
FR2570604B1 (fr) Nouveau procede d'encapsulation de substances volatiles et les compositions phyto-aromatiques ainsi obtenues
DE3567013D1 (en) Perfume compositions and perfumed products which contain one or more 4,7-alkadienals as the essential substance
FR2556721B1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2573077B1 (fr) Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant
IT1171387B (it) Derivati steroidici 20-isonitrili 17(20)-insaturi, procedimento per la loro preparazione, e loro applicazione nella preparazione degli sterioidi 17alfa-idrcssi-20-chetonici
IT1231764B (it) Composizione poliuretanica con capacita' di assorbire umidita', particolarmente adatta per la fabbricazione di cuoio sintetico e simili, e procedimento per la sua produzione.
DE68906205D1 (de) Kosmetische un paramedizinische praeparate.
ES2034392T3 (es) Un producto granular.
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
IT7822222A0 (it) Procedimento per la preparazione di materiali biocompatibili di natura poliammidica e manufatti cosi'ottenuti.
IT1141445B (it) Procedimento di preparazione di solfonati di petrolio,prodotti cosi' ottenuti e loro utilizzazione in particolare nella fabbricazione di micro-emulsioni